| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.34 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |